Highlights; TLDR
We enter 2026 with a clear thesis: healthcare is ready for LLM-native solutions that not only automate workflows but deliver a much better experience for the care team — what we call LLM Magic. With flagship design partners like Grupo Gamma and Swiss Medical validating our approach, a path to 2x our current business and a 14-person team that ships like a company three times its size, we believe that by year-end Wúru will be a highly attractive business — whether as an M&A target or to raise a Series A.
- Profitable year-end: Full-year 2025 net loss of just -$67k on $734k revenue (+94% YoY) — with Q4 alone netting +$39k profit.
- Record platform usage: 1,246 MAU and 48,000+ surgeries supported in Q4, with scheduling automation reaching 32% at our flagship customer.
- 2x growth ahead: 2026 forecast of $1.44M total revenue - $155k MRR in December - , driven by a major network contract conversion, bespoke LLM products, and organic growth.
- Tiny team, big ambitions: 14 people, a new Tech Lead, and a hybrid dev model combining traditional software engineers with agentic builders using N8N and Claude Code.
Product
Key Developments:
- AI assistant re-engineered on N8N agentic framework → conversations are now faster, more focused, and close transactions in fewer messages — saving time for physicians.
- Real-time OR tracking → live visibility into OR status so surgical teams can reduce idle time between cases. More complex than originally scoped; investing in specialized talent.
- Infusion workflow improvements → smoother scheduling for infusion nurses, reducing coordination overhead and wait times.
- 32% scheduling automation at Grupo Gamma (up from 15% in Q3) → validates that meaningful automation of order intake is possible, with a clear path to 50%+.
- Infrastructure reliability strengthened → fewer disruptions mid-workflow, building hospital-grade trust.
- Microsoft partnership extended → zero cloud costs through 2026, saving ~$5k/month reinvested into product.
Usage & Engagement:
